Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biochem Biophys Res Commun ; 452(3): 382-8, 2014 Sep 26.
Artigo em Inglês | MEDLINE | ID: mdl-25157809

RESUMO

Skeletal muscle and adipose tissues are known to be two important insulin target sites. Therefore, lipid induced insulin resistance in these tissues greatly contributes in the development of type 2 diabetes (T2D). Ferulic acid (FRL) purified from the leaves of Hibiscus mutabilis, showed impressive effects in preventing saturated fatty acid (SFA) induced defects in skeletal muscle cells. Impairment of insulin signaling molecules by SFA was significantly waived by FRL. SFA markedly reduced insulin receptor ß (IRß) in skeletal muscle cells, this was affected due to the defects in high mobility group A1 (HMGA1) protein obtruded by phospho-PKCε and that adversely affects IRß mRNA expression. FRL blocked PKCε activation and thereby permitted HMGA1 to activate IRß promoter which improved IR expression deficiency. In high fat diet (HFD) fed diabetic rats, FRL reduced blood glucose level and enhanced lipid uptake activity of adipocytes isolated from adipose tissue. Importantly, FRL suppressed fetuin-A (FetA) gene expression, that reduced circulatory FetA level and since FetA is involved in adipose tissue inflammation, a significant attenuation of proinflammatory cytokines occurred. Collectively, FRL exhibited certain unique features for preventing lipid induced insulin resistance and therefore promises a better therapeutic choice for T2D.


Assuntos
Tecido Adiposo/efeitos dos fármacos , Ácidos Cumáricos/farmacologia , Diabetes Mellitus Experimental/tratamento farmacológico , Hibiscus/química , Hipoglicemiantes/farmacologia , Músculo Esquelético/efeitos dos fármacos , Adipócitos/efeitos dos fármacos , Adipócitos/metabolismo , Tecido Adiposo/metabolismo , Animais , Ácidos Cumáricos/isolamento & purificação , Diabetes Mellitus Experimental/etiologia , Diabetes Mellitus Experimental/genética , Diabetes Mellitus Experimental/metabolismo , Dieta Hiperlipídica , Ácidos Graxos/efeitos adversos , Regulação da Expressão Gênica , Proteína HMGA1a/agonistas , Proteína HMGA1a/genética , Proteína HMGA1a/metabolismo , Hipoglicemiantes/isolamento & purificação , Resistência à Insulina , Masculino , Músculo Esquelético/metabolismo , Folhas de Planta/química , Regiões Promotoras Genéticas , Proteína Quinase C-épsilon/antagonistas & inibidores , Proteína Quinase C-épsilon/genética , Proteína Quinase C-épsilon/metabolismo , Ratos , Ratos Sprague-Dawley , Receptor de Insulina/agonistas , Receptor de Insulina/antagonistas & inibidores , Receptor de Insulina/genética , Receptor de Insulina/metabolismo , Transdução de Sinais , alfa-2-Glicoproteína-HS/antagonistas & inibidores , alfa-2-Glicoproteína-HS/genética , alfa-2-Glicoproteína-HS/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...